NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Aarti Drugs Limited (NSE: AARTIDRUGS)
AARTIDRUGS Technical Analysis
4
As on 26th Dec 2024 AARTIDRUGS SHARE Price closed @ 452.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 501.59 & Sell for SHORT-TERM with Stoploss of 471.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AARTIDRUGSSHARE Price
Open | 469.90 | Change | Price | % |
High | 470.85 | 1 Day | -23.20 | -4.87 |
Low | 451.00 | 1 Week | 20.80 | 4.82 |
Close | 452.70 | 1 Month | -1.40 | -0.31 |
Volume | 598008 | 1 Year | -41.25 | -8.35 |
52 Week High 619.55 | 52 Week Low 317.10 |
NSE INDIA Most Active Stocks
IDEA | 7.56 | 1.34% |
YESBANK | 19.80 | 0.00% |
EASEMYTRIP | 16.91 | 2.67% |
MANAPPURAM | 184.29 | -0.96% |
GTLINFRA | 2.03 | 0.00% |
INTELLECT | 1051.90 | 14.92% |
ZOMATO | 273.20 | -0.60% |
FILATFASH | 0.80 | -4.76% |
TATASTEEL | 140.36 | -0.01% |
JPPOWER | 18.13 | -0.66% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
AARTIDRUGS Daily Charts |
AARTIDRUGS Intraday Charts |
Whats New @ Bazaartrend |
AARTIDRUGS Free Analysis |
|
AARTIDRUGS Important Levels Intraday
RESISTANCE | 490.95 |
RESISTANCE | 478.68 |
RESISTANCE | 471.10 |
RESISTANCE | 463.52 |
SUPPORT | 441.88 |
SUPPORT | 434.30 |
SUPPORT | 426.72 |
SUPPORT | 414.45 |
AARTIDRUGS Target December 2024
4th UP Target | 639.84 |
3rd UP Target | 591.08 |
2nd UP Target | 560.94 |
1st UP Target | 530.8 |
1st DOWN Target | 444.8 |
2nd DOWN Target | 414.66 |
3rd DOWN Target | 384.52 |
4th DOWN Target | 335.76 |
AARTIDRUGS Weekly Target
4th UP Target | 490.59 |
3rd UP Target | 470.60 |
2nd UP Target | 458.24 |
1st UP Target | 445.88 |
1st DOWN Target | 410.62 |
2nd DOWN Target | 398.26 |
3rd DOWN Target | 385.90 |
4th DOWN Target | 365.91 |
AARTIDRUGS Target2024
4th UP Target | 1128.67 |
3rd UP Target | 923.59 |
2nd UP Target | 796.82 |
1st UP Target | 670.06 |
1st DOWN Target | 308.34 |
2nd DOWN Target | 181.58 |
3rd DOWN Target | 54.81 |
4th DOWN Target | -150.27 |
Aarti Drugs Limited ( NSE INDIA Symbol : AARTIDRUGS )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
AARTIDRUGS Synopsis Technicals View
50 Day EMA |
Close is Below EMA 50 (Short Term) |
Bearish | |
100 Day EMA | Close is Below EMA 100 (Mid Term) | Bearish | |
200 Day EMA | Close is Below EMA 200 (Long Term) | Bearish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is Below 30 | Over Sold | |
MFI (14) | MFI is 57.27 | Sideways | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Short Sell | 591.43 | |
10 Day Avg Volume | Traded -36.18 % Less then 10 Day Average Volume |
AARTIDRUGS Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
AARTIDRUGS Address
AARTIDRUGS Latest News
AARTIDRUGS Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service